Therefore, MCP-1/CCL2-related evidence in NAFLD is still controversial, suggesting that MCP-1/CCL2 is not a single pivotal player in this disease and certainly depends on other factors. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatotic liver disease.